Home ›
NPI 1447682380
NPI deactivated
1447682380
1447682380 was paid $1.38M by Medicaid between Jan 2018 and Oct 2022, across 69 billing codes. Its largest line is 87591, Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe — 25% of everything it billed.
33Billing provider info1447682380
33aNPI1447682380
33bProvider type—
28Total paid$1.38M
24GClaims78,680
24DCodes billed69
24AFirst – last monthJan 2018 – Oct 2022
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 27,818 | $597K | |
| 2019 | 14,467 | $319K | |
| 2020 | 15,796 | $202K | |
| 2021 | 17,686 | $199K | |
| 2022 | 2,913 | $60K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | 25% | 11,574 | 11,233 | $349K |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | 25% | 11,497 | 11,167 | $348K |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | 6.5% | 1,015 | 773 | $90K |
| 88175 | Cytopathology, cervical or vaginal, any reporting system; collected in preservative fluid, automated thin layer | 3.9% | 2,478 | 2,352 | $54K |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | 3.8% | 1,040 | 982 | $52K |
| 87624 | Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types | 3.7% | 1,720 | 1,650 | $50K |
| 87661 | Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe | 2.8% | 1,435 | 1,294 | $39K |
| 87512 | 2.7% | 1,117 | 1,038 | $37K | |
| 86480 | 2.6% | 731 | 673 | $36K | |
| 87389 | Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies | 2.5% | 1,903 | 1,775 | $35K |
| 87481 | 2.3% | 984 | 917 | $31K | |
| 81220 | CFTR (cystic fibrosis transmembrane conductance regulator) gene analysis; common variants | 1.9% | 159 | 159 | $26K |
57 more codes
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 1.7% | 6,936 | $23K |
| 87529 | 1.5% | 524 | $21K | |
| 86762 | 1.4% | 1,655 | $19K | |
| 80053 | Comprehensive metabolic panel | 1.3% | 5,884 | $18K |
| 81329 | 1.1% | 152 | $15K | |
| 83036 | Hemoglobin; glycosylated (A1C) | 1.0% | 4,217 | $14K |
| 80061 | Lipid panel | <1% | 4,355 | $13K |
| 87340 | <1% | 1,402 | $10K | |
| 86592 | <1% | 2,846 | $10K | |
| 87798 | Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism | <1% | 118 | $9K |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | <1% | 546 | $9K |
| 86481 | <1% | 138 | $9K | |
| 87653 | <1% | 264 | $7K | |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 1,081 | $7K |
| 87799 | <1% | 96 | $7K | |
| 87070 | <1% | 626 | $4K | |
| 83021 | <1% | 217 | $3K | |
| 87077 | <1% | 397 | $3K | |
| 82951 | <1% | 266 | $3K | |
| 83655 | <1% | 259 | $2K | |
| 86901 | <1% | 1,107 | $2K | |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 398 | $2K |
| 86850 | <1% | 962 | $2K | |
| 86900 | <1% | 1,015 | $2K | |
| 81001 | <1% | 2,451 | $2K | |
| 87186 | <1% | 275 | $2K | |
| 88142 | <1% | 113 | $2K | |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | <1% | 27 | $2K |
| 82950 | <1% | 411 | $2K | |
| 87088 | <1% | 175 | $1K | |
| 86787 | <1% | 87 | $890.88 | |
| 82274 | <1% | 71 | $738.34 | |
| 82947 | <1% | 204 | $625.16 | |
| 86696 | <1% | 18 | $309.60 | |
| 82172 | <1% | 26 | $305.37 | |
| 84550 | <1% | 651 | $263.11 | |
| 86708 | <1% | 21 | $212.73 | |
| 86695 | <1% | 18 | $212.40 | |
| 86735 | <1% | 18 | $187.74 | |
| 86765 | <1% | 18 | $185.40 | |
| 86706 | <1% | 20 | $171.20 | |
| 84154 | <1% | 29 | $145.76 | |
| 82607 | <1% | 29 | $110.88 | |
| 83540 | <1% | 15 | $77.25 | |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 343 | $51.19 |
| 82570 | <1% | 12 | $50.64 | |
| 82952 | <1% | 13 | $40.43 | |
| 36415 | Collection of venous blood by venipuncture | <1% | 1,079 | $29.52 |
| 85651 | <1% | 160 | $26.71 | |
| 85027 | <1% | 556 | $20.45 | |
| 82248 | <1% | 186 | $15.85 | |
| 80076 | <1% | 190 | $11.88 | |
| 80069 | <1% | 240 | $6.62 | |
| 82565 | <1% | 58 | $6.04 | |
| 85610 | <1% | 15 | $0.61 | |
| 84460 | 0% | 24 | $0.00 | |
| 84100 | 0% | 13 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.